KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BeOne Medicines (ONC) Intangibles (2017 - 2025)

Historic Intangibles for BeOne Medicines (ONC) over the last 9 years, with Q3 2025 value amounting to $63.6 million.

  • BeOne Medicines' Intangibles rose 1787.57% to $63.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $63.6 million, marking a year-over-year increase of 1787.57%. This contributed to the annual value of $51.1 million for FY2024, which is 1057.61% down from last year.
  • As of Q3 2025, BeOne Medicines' Intangibles stood at $63.6 million, which was up 1787.57% from $64.9 million recorded in Q2 2025.
  • Over the past 5 years, BeOne Medicines' Intangibles peaked at $64.9 million during Q2 2025, and registered a low of $4.8 million during Q1 2021.
  • For the 5-year period, BeOne Medicines' Intangibles averaged around $44.1 million, with its median value being $46.9 million (2023).
  • Its Intangibles has fluctuated over the past 5 years, first plummeted by 1348.19% in 2021, then skyrocketed by 85173.49% in 2022.
  • Over the past 5 years, BeOne Medicines' Intangibles (Quarter) stood at $46.7 million in 2021, then fell by 12.99% to $40.6 million in 2022, then soared by 40.68% to $57.1 million in 2023, then fell by 10.58% to $51.1 million in 2024, then grew by 24.44% to $63.6 million in 2025.
  • Its last three reported values are $63.6 million in Q3 2025, $64.9 million for Q2 2025, and $50.1 million during Q1 2025.